Gabather hos Aktieportföljen Live
Interview with Gabather's CEO Michael-Robin Witt

Analyst Group interview Gabather's CEO Michael-Robin Witt in connection to the company's rights issue 2023. 

1
2
3
4

Articles about Gabather

2023-12-14
Presentation från investerarträff
2023-06-29
Presentation from Q&A
2023-03-02
BioStock: Investor Pitch: Gabather
2022-12-23
BioStock: Gabather's aims to impact the neurodegeneration field
2022-11-04
Biostock: Gabather approaching initial target engagement study results
2022-06-02
Biostock: Gabather's lead candidate moves forward in the clinic
2021-05-10
Biostock: Covid unmasks need for better mental health medication
2021-03-25
Biostock Studio: Gabather gives clinical trial update
2021-02-22
Biostock: Q4 report points to progress in the clinic for Gabather